Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 308

1.

Unclassified hepatocellular adenoma expressing ASS1 associated with inflammatory hepatocellular adenomas.

Frulio N, Balabaud C, Laurent C, Trillaud H, Bioulac-Sage P.

Clin Res Hepatol Gastroenterol. 2019 Apr 29. pii: S2210-7401(19)30089-0. doi: 10.1016/j.clinre.2019.03.012. [Epub ahead of print]

PMID:
31047837
2.

Repeat surgery in HNF1alpha-inactivated adenomatosis.

Balabaud C, Laurent C, Frulio N, Marie Christine SP, Le Bail B, Possenti L, Blanc JF, Chiche L, Bioulac-Sage P.

Clin Res Hepatol Gastroenterol. 2019 Mar 19. pii: S2210-7401(18)30257-2. doi: 10.1016/j.clinre.2018.11.001. [Epub ahead of print]

PMID:
30902584
3.

Actin Depolymerization in Dedifferentiated Liver Sinusoidal Endothelial Cells Promotes Fenestrae Re-Formation.

Di Martino J, Mascalchi P, Legros P, Lacomme S, Gontier E, Bioulac-Sage P, Balabaud C, Moreau V, Saltel F.

Hepatol Commun. 2018 Dec 28;3(2):213-219. doi: 10.1002/hep4.1301. eCollection 2019 Feb.

4.

New MRI features improve subtype classification of hepatocellular adenoma.

Bise S, Frulio N, Hocquelet A, Alberti N, Blanc JF, Laurent C, Laumonier H, Balabaud C, Bioulac-Sage P, Trillaud H.

Eur Radiol. 2019 May;29(5):2436-2447. doi: 10.1007/s00330-018-5784-5. Epub 2018 Dec 6.

PMID:
30523457
5.

OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.

Sciarra A, Schmidt S, Pellegrinelli A, Maggioni M, Dondossola D, Pasquier J, Cigala C, Tosi D, Halkic N, Bulfamante G, Viale G, Bosari S, Balabaud C, Bioulac-Sage P, Sempoux C.

Liver Int. 2019 Jan;39(1):158-167. doi: 10.1111/liv.13964. Epub 2018 Oct 8.

PMID:
30218633
6.

Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes.

Bioulac-Sage P, Sempoux C, Frulio N, Le Bail B, Blanc JF, Castain C, Laurent C, Trillaud H, Chiche L, Balabaud C.

Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):12-19. doi: 10.1016/j.clinre.2018.07.007. Epub 2018 Sep 10.

PMID:
30213653
7.

A difficult case of β-catenin-mutated hepatocellular adenoma: a lesson for diagnosis.

Cappellen D, Balabaud C, Bioulac-Sage P.

Histopathology. 2019 Jan;74(2):355-357. doi: 10.1111/his.13751. Epub 2018 Dec 6. No abstract available.

PMID:
30184258
8.

Collision of hepatocellular nodules in vascular livers: A medical challenge.

Le Bail B, Chiche L, Balabaud C, Bioulac-Sage P.

Clin Res Hepatol Gastroenterol. 2018 Oct;42(5):e83-e85. doi: 10.1016/j.clinre.2017.11.001. Epub 2018 Aug 23. No abstract available.

PMID:
30145279
9.

Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition.

Guido M, Alves VAF, Balabaud C, Bathal PS, Bioulac-Sage P, Colombari R, Crawford JM, Dhillon AP, Ferrell LD, Gill RM, Hytiroglou P, Nakanuma Y, Paradis V, Quaglia A, Rautou PE, Theise ND, Thung S, Tsui WMS, Sempoux C, Snover D, van Leeuwen DJ; International Liver Pathology Study Group.

Histopathology. 2019 Jan;74(2):219-226. doi: 10.1111/his.13738. Epub 2018 Oct 17. Review.

PMID:
30129657
10.

STED microscopy: A simplified method for liver sinusoidal endothelial fenestrae analysis.

Di Martino J, Mascalchi P, Legros P, Lacomme S, Gontier E, Bioulac-Sage P, Balabaud C, Moreau V, Saltel F.

Biol Cell. 2018 Jul;110(7):159-168. doi: 10.1111/boc.201800016. Epub 2018 Jun 25.

PMID:
29808906
11.

Acute-on-chronic liver failure 2018: a need for (urgent) liver biopsy?

van Leeuwen DJ, Alves V, Balabaud C, Bhathal PS, Bioulac-Sage P, Colombari R, Crawford JM, Dhillon AP, Ferrell L, Gill RM, Guido M, Hytiroglou P, Nakanuma Y, Paradis V, Rautou PE, Sempoux C, Snover DC, Theise ND, Thung SN, Tsui WMS, Quaglia A, Liver Pathology Study Group TI.

Expert Rev Gastroenterol Hepatol. 2018 Jun;12(6):565-573. doi: 10.1080/17474124.2018.1481388. Epub 2018 Jun 14. Review.

PMID:
29806950
12.

Hepatocellular nodules in vascular liver diseases.

Sempoux C, Balabaud C, Paradis V, Bioulac-Sage P.

Virchows Arch. 2018 Jul;473(1):33-44. doi: 10.1007/s00428-018-2373-6. Epub 2018 May 26. Review.

PMID:
29804132
13.

Unexpected discovery of small HNF1α-inactivated hepatocellular adenoma in pathological specimens from patients resected for liver tumours.

Balabaud C, Laurent C, Le Bail B, Castain C, Possenti L, Frulio N, Chiche L, Blanc JF, Bioulac-Sage P.

Liver Int. 2018 Jul;38(7):1273-1279. doi: 10.1111/liv.13667. Epub 2018 Jan 17.

PMID:
29265678
14.

Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.

Henriet E, Abou Hammoud A, Dupuy JW, Dartigues B, Ezzoukry Z, Dugot-Senant N, Leste-Lasserre T, Pallares-Lupon N, Nikolski M, Le Bail B, Blanc JF, Balabaud C, Bioulac-Sage P, Raymond AA, Saltel F.

Hepatology. 2017 Dec;66(6):2016-2028. doi: 10.1002/hep.29336. Epub 2017 Oct 30.

PMID:
28646562
15.

Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.

Saldarriaga J, Bisig B, Couchy G, Castain C, Zucman-Rossi J, Balabaud C, Sempoux C, Bioulac-Sage P.

Histopathology. 2017 Dec;71(6):989-993. doi: 10.1111/his.13283. Epub 2017 Oct 6.

PMID:
28618047
16.

Hepatocellular Adenomas: Morphology and Genomics.

Bioulac-Sage P, Sempoux C, Balabaud C.

Gastroenterol Clin North Am. 2017 Jun;46(2):253-272. doi: 10.1016/j.gtc.2017.01.003. Review.

PMID:
28506364
17.

Hepatocellular adenoma: Classification, variants and clinical relevance.

Bioulac-Sage P, Sempoux C, Balabaud C.

Semin Diagn Pathol. 2017 Mar;34(2):112-125. doi: 10.1053/j.semdp.2016.12.007. Epub 2016 Dec 20. Review.

PMID:
28131467
18.

Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before.

Sempoux C, Bisig B, Couchy G, Balabaud C, Zucman-Rossi J, Bioulac-Sage P.

Hum Pathol. 2017 Apr;62:122-125. doi: 10.1016/j.humpath.2016.10.004. Epub 2016 Oct 28.

PMID:
27984126
19.

Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.

Nault JC, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc JF, Bacq Y, Calderaro J, Paradis V, Ramos J, Scoazec JY, Gnemmi V, Sturm N, Guettier C, Fabre M, Savier E, Chiche L, Labrune P, Selves J, Wendum D, Pilati C, Laurent A, De Muret A, Le Bail B, Rebouissou S, Imbeaud S; GENTHEP Investigators, Bioulac-Sage P, Letouzé E, Zucman-Rossi J.

Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.

20.

TGF-β1 promotes linear invadosome formation in hepatocellular carcinoma cells, through DDR1 up-regulation and collagen I cross-linking.

Ezzoukhry Z, Henriet E, Piquet L, Boyé K, Bioulac-Sage P, Balabaud C, Couchy G, Zucman-Rossi J, Moreau V, Saltel F.

Eur J Cell Biol. 2016 Nov;95(11):503-512. doi: 10.1016/j.ejcb.2016.09.003. Epub 2016 Oct 4.

PMID:
27720259
21.

Genotype-phenotype correlation of CTNNB1 mutations reveals different ß-catenin activity associated with liver tumor progression.

Rebouissou S, Franconi A, Calderaro J, Letouzé E, Imbeaud S, Pilati C, Nault JC, Couchy G, Laurent A, Balabaud C, Bioulac-Sage P, Zucman-Rossi J.

Hepatology. 2016 Dec;64(6):2047-2061. doi: 10.1002/hep.28638. Epub 2016 Jun 11.

PMID:
27177928
22.

Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV.

Nault JC, Mami I, La Bella T, Datta S, Imbeaud S, Franconi A, Mallet M, Couchy G, Letouzé E, Pilati C, Verret B, Blanc JF, Balabaud C, Calderaro J, Laurent A, Letexier M, Bioulac-Sage P, Calvo F, Zucman-Rossi J.

Mol Ther. 2016 Apr;24(4):660-1. doi: 10.1038/mt.2016.47. No abstract available.

23.

AAV2 and Hepatocellular Carcinoma.

Nault JC, Datta S, Imbeaud S, Franconi A, Mallet M, Couchy G, Letouzé E, Pilati C, Verret B, Blanc JF, Balabaud C, Calderaro J, Laurent A, Letexier M, Bioulac-Sage P, Calvo F, Zucman-Rossi J.

Hum Gene Ther. 2016 Mar;27(3):211-3. doi: 10.1089/hum.2016.002. No abstract available.

PMID:
26935016
24.

Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation.

Quaglia A, Alves VA, Balabaud C, Bhathal PS, Bioulac-Sage P, Crawford JM, Dhillon AP, Ferrell L, Guido M, Hytiroglou P, Nakanuma Y, Paradis V, Snover DC, Theise ND, Thung SN, Tsui WM, van Leeuwen DJ; International Liver Pathology Study Group.

Histopathology. 2016 Jun;68(7):953-67. doi: 10.1111/his.12957. Epub 2016 Apr 28. Review.

PMID:
26918878
25.

Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis.

Calderaro J, Nault JC, Balabaud C, Couchy G, Saint-Paul MC, Azoulay D, Mehdaoui D, Luciani A, Zafrani ES, Bioulac-Sage P, Zucman-Rossi J.

Mod Pathol. 2016 Jan;29(1):43-50. doi: 10.1038/modpathol.2015.119. Epub 2015 Oct 30.

26.

Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.

Nault JC, Datta S, Imbeaud S, Franconi A, Mallet M, Couchy G, Letouzé E, Pilati C, Verret B, Blanc JF, Balabaud C, Calderaro J, Laurent A, Letexier M, Bioulac-Sage P, Calvo F, Zucman-Rossi J.

Nat Genet. 2015 Oct;47(10):1187-93. doi: 10.1038/ng.3389. Epub 2015 Aug 24.

PMID:
26301494
27.

Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA.

Shih A, Lauwers GY, Balabaud C, Bioulac-Sage P, Misdraji J.

Am J Surg Pathol. 2015 Sep;39(9):1296-300. doi: 10.1097/PAS.0000000000000477.

PMID:
26274031
28.

Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders.

Sempoux C, Paradis V, Komuta M, Wee A, Calderaro J, Balabaud C, Quaglia A, Bioulac-Sage P.

J Hepatol. 2015 Nov;63(5):1173-80. doi: 10.1016/j.jhep.2015.06.017. Epub 2015 Jun 25.

PMID:
26119687
29.

Hepatocellular adenoma management: advances but still a long way to go.

Blanc JF, Frulio N, Chiche L, Bioulac-Sage P, Balabaud C.

Hepat Oncol. 2015 Apr;2(2):171-180. doi: 10.2217/hep.14.41. Epub 2015 May 15. Review.

30.

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.

Schulze K, Imbeaud S, Letouzé E, Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C, Shinde J, Soysouvanh F, Calatayud AL, Pinyol R, Pelletier L, Balabaud C, Laurent A, Blanc JF, Mazzaferro V, Calvo F, Villanueva A, Nault JC, Bioulac-Sage P, Stratton MR, Llovet JM, Zucman-Rossi J.

Nat Genet. 2015 May;47(5):505-511. doi: 10.1038/ng.3252. Epub 2015 Mar 30.

31.

Well-differentiated hepatocellular neoplasm of uncertain malignant potential.

Balabaud C, Bioulac-Sage P, Ferrell L, Kakar S, Paradis V, Quaglia A, Sempoux C, Thung S, Zucman-Rossi J.

Hum Pathol. 2015 Apr;46(4):634-5. doi: 10.1016/j.humpath.2014.10.029. Epub 2014 Dec 31. No abstract available.

PMID:
25661243
32.

Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.

Blanc JF, Frulio N, Chiche L, Sempoux C, Annet L, Hubert C, Gouw AS, de Jong KP, Bioulac-Sage P, Balabaud C.

Clin Res Hepatol Gastroenterol. 2015 Apr;39(2):180-7. doi: 10.1016/j.clinre.2014.10.003. Epub 2014 Nov 26.

PMID:
25434466
33.

Malignant transformation of hepatocellular adenoma.

Sempoux C, Balabaud C, Bioulac-Sage P.

Hepat Oncol. 2014 Oct;1(4):421-431. doi: 10.2217/hep.14.14. Epub 2014 Dec 11. Review.

34.

Pictures of focal nodular hyperplasia and hepatocellular adenomas.

Sempoux C, Balabaud C, Bioulac-Sage P.

World J Hepatol. 2014 Aug 27;6(8):580-95. doi: 10.4254/wjh.v6.i8.580. Review.

35.

Integrative quantitative proteomics unveils proteostasis imbalance in human hepatocellular carcinoma developed on nonfibrotic livers.

Negroni L, Taouji S, Arma D, Pallares-Lupon N, Leong K, Beausang LA, Latterich M, Bossé R, Balabaud C, Schmitter JM, Bioulac-Sage P, Zucman-Rossi J, Rosenbaum J, Chevet E.

Mol Cell Proteomics. 2014 Dec;13(12):3473-83. doi: 10.1074/mcp.M114.043174. Epub 2014 Sep 15.

36.

Glutamine synthetase interpretation in hepatocellular adenoma.

Balabaud C, Bioulac-Sage P.

Virchows Arch. 2014 Oct;465(4):495-6. doi: 10.1007/s00428-014-1649-8. Epub 2014 Sep 13. No abstract available.

PMID:
25216583
37.

Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.

Nault JC, Calderaro J, Di Tommaso L, Balabaud C, Zafrani ES, Bioulac-Sage P, Roncalli M, Zucman-Rossi J.

Hepatology. 2014 Dec;60(6):1983-92. doi: 10.1002/hep.27372. Epub 2014 Oct 27.

PMID:
25123086
38.

Congenital hepatic fibrosis with multiple HNF1α hepatocellular adenomas.

Paradis V, Bioulac-Sage P, Balabaud C.

Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):e115-6. doi: 10.1016/j.clinre.2014.03.011. Epub 2014 Jun 26. No abstract available.

PMID:
24981780
39.

Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.

Pilati C, Letouzé E, Nault JC, Imbeaud S, Boulai A, Calderaro J, Poussin K, Franconi A, Couchy G, Morcrette G, Mallet M, Taouji S, Balabaud C, Terris B, Canal F, Paradis V, Scoazec JY, de Muret A, Guettier C, Bioulac-Sage P, Chevet E, Calvo F, Zucman-Rossi J.

Cancer Cell. 2014 Apr 14;25(4):428-41. doi: 10.1016/j.ccr.2014.03.005.

40.

Immunohistochemical pitfalls in the diagnosis of focal nodular hyperplasia and inflammatory hepatocellular adenoma.

Bioulac-Sage P, Sempoux C, Balabaud C.

Clin Res Hepatol Gastroenterol. 2014 Jun;38(3):245-9. doi: 10.1016/j.clinre.2014.01.001. Epub 2014 Feb 10. No abstract available.

PMID:
24525010
41.

Smoothelin, a new marker to determine the origin of liver fibrogenic cells.

Lepreux S, Guyot C, Billet F, Combe C, Balabaud C, Bioulac-Sage P, Desmoulière A.

World J Gastroenterol. 2013 Dec 28;19(48):9343-50. doi: 10.3748/wjg.v19.i48.9343.

42.

Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association?

Castain C, Sempoux C, Brunt EM, Causse O, Heitzmann A, Hernandez-Prera JC, Le Bail B, Schirmacher P, Thung SN, Balabaud C, Bioulac-Sage P.

Histopathology. 2014 May;64(6):890-5. doi: 10.1111/his.12326. Epub 2014 Jan 24.

PMID:
24236804
43.

Interest of contrast-enhanced sonography to identify focal nodular hyperplasia with sinusoidal dilatation.

Alberti N, Frulio N, Bioulac-Sage P, Laumonier H, Balabaud C, Perez JT, Teixeira FR Jr, Harbonnier N, Trillaud H.

Diagn Interv Imaging. 2014 Jan;95(1):77-83. doi: 10.1016/j.diii.2013.09.002. Epub 2013 Oct 15.

44.

Hepatocellular adenomatosis: what should the term stand for!

Frulio N, Chiche L, Bioulac-Sage P, Balabaud C.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):132-6. doi: 10.1016/j.clinre.2013.08.004. Epub 2013 Oct 11. Review.

PMID:
24126236
45.

Changes in the management of benign liver tumors.

Bioulac-Sage P, Chiche L, Balabaud C.

Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):444-6. doi: 10.1016/j.clinre.2013.06.013. Epub 2013 Aug 12. No abstract available.

PMID:
23948444
46.

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.

Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J.

Nat Commun. 2013;4:2218. doi: 10.1038/ncomms3218. Erratum in: Nat Commun. 2013;4:2577. Zucman Rossi, Jessica [corrected to Zucman-Rossi, Jessica].

47.

Benign hepatocellular nodules: what have we learned using the patho-molecular classification.

Sempoux C, Chang C, Gouw A, Chiche L, Zucman-Rossi J, Balabaud C, Bioulac-Sage P.

Clin Res Hepatol Gastroenterol. 2013 Sep;37(4):322-7. doi: 10.1016/j.clinre.2013.04.008. Epub 2013 Jul 19. Review.

PMID:
23876350
48.

Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification.

Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A, Schirmacher P, Sempoux C, Thung SN, Torbenson M, Wee A, Yeh MM, Yeh SH, Le Bail B, Zucman-Rossi J, Bioulac-Sage P.

Int J Hepatol. 2013;2013:268625. doi: 10.1155/2013/268625. Epub 2013 Apr 14.

49.

Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context.

Bioulac-Sage P, Sempoux C, Possenti L, Frulio N, Laumonier H, Laurent C, Chiche L, Frédéric Blanc J, Saric J, Trillaud H, Le Bail B, Balabaud C.

Int J Hepatol. 2013;2013:253261. doi: 10.1155/2013/253261. Epub 2013 Apr 18.

50.

Reply: To PMID 23269717.

Frulio N, Laumonier H, Carteret T, Laurent C, Balabaud C, Bioulac-Sage P, Maire F, Trillaud H.

J Ultrasound Med. 2013 May;32(5):889-90. doi: 10.7863/ultra.32.5.889. No abstract available.

PMID:
23620334

Supplemental Content

Loading ...
Support Center